VeriMompalmitoyl tripeptide-56 hamilelikte güvenli mi?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR reproductive safety flags were identified for palmitoyl tripeptide-56. No peer‑reviewed reports of developmental/reproductive toxicity were found in the literature. Topical peptides of this class are large molecules with low systemic absorption, but palmitoylation increases lipophilicity so low but measurable dermal uptake is plausible (hence e=1). Sources: ECHA Annex VI (no harmonised classification), CIR (no safety concern noted for cosmetic peptides generally), PubMed (no reproductive/toxicity studies found).
Pregnancy-safe products containing palmitoyl tripeptide-56
Related ingredients
Frequently asked questions
- palmitoyl tripeptide-56 hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR reproductive safety flags were identified for palmitoyl tripeptide-56. No peer‑reviewed reports of developmental/reproductive toxicity were found in the literature. Topical peptides of this class are large molecules with low systemic absorption, but palmitoylation increases lipophilicity so low but measurable dermal uptake is plausible (hence e=1). Sources: ECHA Annex VI (no harmonised classification), CIR (no safety concern noted for cosmetic peptides generally), PubMed (no reproductive/toxicity studies found).
- palmitoyl tripeptide-56 emzirirken güvenli mi?
- No evidence of reproductive or lactation-specific toxicity; no mechanistic data indicating transfer into breastmilk. Given low expected systemic exposure after topical use, systemic levels are likely minimal but not zero, so exposure is low/measurable. Sources: PubMed (no relevant studies), ECHA (no harmonised classification), PubChem/CosIng (ingredient identity/uses).
- palmitoyl tripeptide-56 bebek cildi için güvenli mi?
- No infant‑specific toxicity or developmental effects reported. Per guidance, infant skin has higher per‑kg exposure and a less mature barrier; for an ingredient with low but measurable adult absorption (e=1), increase exposure score by +1 for babies (e=2). No data support increased hazard or specific mechanisms in infants. Sources: PubMed (no infant toxicity data), CosIng/PubChem (ingredient info).
- VeriMom palmitoyl tripeptide-56 nasıl puanlıyor?
- VeriMom palmitoyl tripeptide-56'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte palmitoyl tripeptide-56 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.